Mutual Reliance Blossoming Among U.S. FDA, EMA, Other Inspectorates
This article was originally published in PharmAsia News
U.S. FDA, EMA and other agencies are increasingly relying on each others' inspection results in an effort to spread their inspectional resources throughout the furthest corners of the globe.
You may also be interested in...
Just as they did during the heparin crisis a decade ago, pharmaceutical companies must coordinate on coronavirus, Rx-360 CEO says.